In this study, the CKD patients were classified into different groups according to the severity of CKD and the results obtained suggested that both AQP1 and AQP2 were decreased in uECVs from patients with advanced CKD and could serve as new biomarkers for the diagnoses of advanced CKD [39]. This evidence concerns the gene AQP2 and chronic kidney disease.